The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...

Investing.com -- Wall Street analysts initiated coverage on Metsera with bullish outlook given the biotech firm’s ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...

On February 3, three insiders purchased a total of around $94.22 million worth of Metsera shares during the company’s initial ...

IPO GMP Live: Quality Power day 3 subscription, Hexaware allotment in focus today - Check price band, GMP, listing dates & more IPO GMP News Latest Updates (February 18): The initial public ...

Hexaware Technologies IPO Allotment: The initial public offering (IPO) of global digital and technology services company Hexaware Technologies Ltd received decent response. Investors now focus on ...

Online fast-fashion retailer Shein is under pressure to cut its valuation to about $30 billion ahead of its London listing, Bloomberg News reported on Monday, citing people familiar with the matter.

The initial public offering (IPO) of Quality Power Electrical Equipments continued to attract a mixed response from the investors during the second day of the bidding process from all the ...